Cyagen is a global provider of genetically modified rodent models and innovative cell and gene therapy solutions for research and development (R&D), including: disease model development, AAV discovery, drug efficacy studies, and more. Cyagen currently has over 900 employees and multiple facilities with a total scale of over 40,000 square meters, including our US headquarters in Santa Clara, California, and additional locations in Japan and China. The company has established extensive cooperations with scientists and institutions in more than 100 countries, leading to the publication of over 6,300 academic articles, many of which were in the three major journals of CNS (Cell, Nature, Science).